Zhejiang Int'L Group Co Ltd
Zhejiang Int'l Group Co.,Ltd. engages in the wholesale and retail of pharmaceuticals and medical devices. It offers chemical drugs, biological products, and Chinese patent medicine. The company was founded in 1950 and is based in Hangzhou, China.
Zhejiang Int'L Group Co Ltd (000411) - Net Assets
Latest net assets as of September 2025: CN¥5.36 Billion CNY
Based on the latest financial reports, Zhejiang Int'L Group Co Ltd (000411) has net assets worth CN¥5.36 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥17.31 Billion) and total liabilities (CN¥11.95 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥5.36 Billion |
| % of Total Assets | 30.97% |
| Annual Growth Rate | 12.2% |
| 5-Year Change | 62.5% |
| 10-Year Change | 243.73% |
| Growth Volatility | 32.37 |
Zhejiang Int'L Group Co Ltd - Net Assets Trend (1993–2024)
This chart illustrates how Zhejiang Int'L Group Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Zhejiang Int'L Group Co Ltd (1993–2024)
The table below shows the annual net assets of Zhejiang Int'L Group Co Ltd from 1993 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥5.21 Billion | +8.96% |
| 2023-12-31 | CN¥4.78 Billion | +23.13% |
| 2022-12-31 | CN¥3.88 Billion | +10.45% |
| 2021-12-31 | CN¥3.52 Billion | +9.66% |
| 2020-12-31 | CN¥3.21 Billion | +7.89% |
| 2019-12-31 | CN¥2.97 Billion | +42.63% |
| 2018-12-31 | CN¥2.08 Billion | +9.35% |
| 2017-12-31 | CN¥1.91 Billion | +12.28% |
| 2016-12-31 | CN¥1.70 Billion | +11.96% |
| 2015-12-31 | CN¥1.52 Billion | +10.89% |
| 2014-12-31 | CN¥1.37 Billion | +9.76% |
| 2013-12-31 | CN¥1.25 Billion | +18.85% |
| 2012-12-31 | CN¥1.05 Billion | +14.27% |
| 2011-12-31 | CN¥916.87 Million | +100.06% |
| 2010-12-31 | CN¥458.30 Million | +32.01% |
| 2009-12-31 | CN¥347.19 Million | +23.09% |
| 2008-12-31 | CN¥282.07 Million | +5.16% |
| 2007-12-31 | CN¥268.23 Million | +24.23% |
| 2006-12-31 | CN¥215.92 Million | +13.98% |
| 2005-12-31 | CN¥189.44 Million | +4.83% |
| 2004-12-31 | CN¥180.71 Million | +4.63% |
| 2003-12-31 | CN¥172.72 Million | +89.04% |
| 2002-12-31 | CN¥91.37 Million | +1.40% |
| 2001-12-31 | CN¥90.10 Million | +94.02% |
| 2000-12-31 | CN¥46.44 Million | -64.30% |
| 1999-12-31 | CN¥130.09 Million | -49.88% |
| 1998-12-31 | CN¥259.55 Million | -13.36% |
| 1997-12-31 | CN¥299.57 Million | +18.06% |
| 1996-12-31 | CN¥253.74 Million | +32.09% |
| 1995-12-31 | CN¥192.09 Million | +8.41% |
| 1994-12-31 | CN¥177.19 Million | +20.50% |
| 1993-12-31 | CN¥147.05 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Zhejiang Int'L Group Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1173290.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥1.98 Billion | 42.69% |
| Common Stock | CN¥522.15 Million | 11.26% |
| Other Components | CN¥2.14 Billion | 46.05% |
| Total Equity | CN¥4.64 Billion | 100.00% |
Zhejiang Int'L Group Co Ltd Competitors by Market Cap
The table below lists competitors of Zhejiang Int'L Group Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Incar Financial Service Co. Ltd.
KQ:211050
|
$199.04 Million |
|
BTB Real Estate Investment Trust
PINK:BTBIF
|
$199.14 Million |
|
Aurora Cannabis Inc
NASDAQ:ACB
|
$199.15 Million |
|
Phoenix Pioneer technology Co., Ltd.
TWO:6920
|
$199.16 Million |
|
Fraser and Neave Limited
PINK:FNEVF
|
$198.99 Million |
|
Dagi Yatirim Holding AS
IS:DAGHL
|
$198.92 Million |
|
Bioteque
TWO:4107
|
$198.92 Million |
|
Ningbo Fubang
SHG:600768
|
$198.92 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Zhejiang Int'L Group Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 4,253,450,158 to 4,637,220,801, a change of 383,770,643 (9.0%).
- Net income of 525,522,107 contributed positively to equity growth.
- Dividend payments of 295,188,496 reduced retained earnings.
- Share repurchases of 1,405,964 reduced equity.
- Other comprehensive income decreased equity by 73,335,781.
- Other factors increased equity by 228,178,777.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥525.52 Million | +11.33% |
| Dividends Paid | CN¥295.19 Million | -6.37% |
| Share Repurchases | CN¥1.41 Million | -0.03% |
| Other Comprehensive Income | CN¥-73.34 Million | -1.58% |
| Other Changes | CN¥228.18 Million | +4.92% |
| Total Change | CN¥- | 9.02% |
Book Value vs Market Value Analysis
This analysis compares Zhejiang Int'L Group Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.32x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 15.51x to 1.32x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1993-12-31 | CN¥0.73 | CN¥11.35 | x |
| 1994-12-31 | CN¥0.88 | CN¥11.35 | x |
| 1995-12-31 | CN¥0.95 | CN¥11.35 | x |
| 1996-12-31 | CN¥1.26 | CN¥11.35 | x |
| 1997-12-31 | CN¥1.43 | CN¥11.35 | x |
| 1998-12-31 | CN¥1.23 | CN¥11.35 | x |
| 1999-12-31 | CN¥0.59 | CN¥11.35 | x |
| 2000-12-31 | CN¥0.22 | CN¥11.35 | x |
| 2001-12-31 | CN¥0.37 | CN¥11.35 | x |
| 2002-12-31 | CN¥0.38 | CN¥11.35 | x |
| 2003-12-31 | CN¥0.41 | CN¥11.35 | x |
| 2004-12-31 | CN¥0.41 | CN¥11.35 | x |
| 2005-12-31 | CN¥0.41 | CN¥11.35 | x |
| 2006-12-31 | CN¥0.37 | CN¥11.35 | x |
| 2007-12-31 | CN¥0.56 | CN¥11.35 | x |
| 2008-12-31 | CN¥0.54 | CN¥11.35 | x |
| 2009-12-31 | CN¥0.68 | CN¥11.35 | x |
| 2010-12-31 | CN¥0.87 | CN¥11.35 | x |
| 2011-12-31 | CN¥1.62 | CN¥11.35 | x |
| 2012-12-31 | CN¥1.90 | CN¥11.35 | x |
| 2013-12-31 | CN¥2.20 | CN¥11.35 | x |
| 2014-12-31 | CN¥2.48 | CN¥11.35 | x |
| 2015-12-31 | CN¥2.70 | CN¥11.35 | x |
| 2016-12-31 | CN¥3.06 | CN¥11.35 | x |
| 2017-12-31 | CN¥3.37 | CN¥11.35 | x |
| 2018-12-31 | CN¥3.72 | CN¥11.35 | x |
| 2019-12-31 | CN¥5.52 | CN¥11.35 | x |
| 2020-12-31 | CN¥5.56 | CN¥11.35 | x |
| 2021-12-31 | CN¥5.93 | CN¥11.35 | x |
| 2022-12-31 | CN¥6.38 | CN¥11.35 | x |
| 2023-12-31 | CN¥8.96 | CN¥11.35 | x |
| 2024-12-31 | CN¥8.61 | CN¥11.35 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Zhejiang Int'L Group Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.33%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.58%
- • Asset Turnover: 2.28x
- • Equity Multiplier: 3.16x
- Recent ROE (11.33%) is above the historical average (4.89%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1993 | 19.52% | 21.98% | 0.54x | 1.63x | CN¥14.00 Million |
| 1994 | 13.55% | 14.45% | 0.58x | 1.63x | CN¥6.30 Million |
| 1995 | 7.50% | 9.62% | 0.39x | 2.00x | CN¥-4.78 Million |
| 1996 | 7.37% | 15.65% | 0.24x | 1.93x | CN¥-6.65 Million |
| 1997 | 11.57% | 19.25% | 0.31x | 1.91x | CN¥4.49 Million |
| 1998 | -16.02% | -39.10% | 0.19x | 2.13x | CN¥-64.06 Million |
| 1999 | -58.39% | -84.96% | 0.19x | 3.64x | CN¥-80.87 Million |
| 2000 | -165.22% | -83.05% | 0.30x | 6.56x | CN¥-78.12 Million |
| 2001 | 12.78% | 39.37% | 0.04x | 8.10x | CN¥2.05 Million |
| 2002 | 1.34% | 0.07% | 1.99x | 9.01x | CN¥-6.68 Million |
| 2003 | 7.38% | 0.37% | 2.14x | 9.25x | CN¥-2.17 Million |
| 2004 | 0.58% | 0.02% | 2.33x | 10.74x | CN¥-7.83 Million |
| 2005 | 7.07% | 0.24% | 2.45x | 12.26x | CN¥-2.41 Million |
| 2006 | 7.57% | 0.25% | 2.40x | 12.71x | CN¥-2.19 Million |
| 2007 | 12.38% | 0.43% | 2.59x | 11.13x | CN¥2.79 Million |
| 2008 | 14.13% | 0.46% | 2.79x | 10.92x | CN¥5.57 Million |
| 2009 | 18.40% | 0.62% | 2.75x | 10.83x | CN¥14.34 Million |
| 2010 | 19.27% | 0.64% | 2.69x | 11.20x | CN¥20.39 Million |
| 2011 | 46.35% | 2.20% | 2.32x | 9.11x | CN¥146.87 Million |
| 2012 | 14.46% | 0.64% | 2.58x | 8.78x | CN¥20.86 Million |
| 2013 | 13.67% | 0.60% | 2.58x | 8.85x | CN¥19.87 Million |
| 2014 | 10.76% | 0.47% | 2.70x | 8.56x | CN¥4.60 Million |
| 2015 | 10.20% | 0.44% | 2.53x | 9.09x | CN¥1.36 Million |
| 2016 | 11.45% | 0.50% | 2.47x | 9.21x | CN¥10.98 Million |
| 2017 | 9.90% | 0.44% | 2.08x | 10.77x | CN¥-849.26K |
| 2018 | 10.09% | 0.46% | 2.28x | 9.67x | CN¥821.30K |
| 2019 | 22.26% | 1.37% | 2.28x | 7.10x | CN¥185.96 Million |
| 2020 | 20.65% | 1.37% | 2.22x | 6.78x | CN¥176.81 Million |
| 2021 | 20.89% | 1.48% | 2.18x | 6.46x | CN¥206.55 Million |
| 2022 | 22.20% | 1.51% | 2.33x | 6.32x | CN¥254.16 Million |
| 2023 | 11.49% | 1.52% | 2.30x | 3.27x | CN¥63.39 Million |
| 2024 | 11.33% | 1.58% | 2.28x | 3.16x | CN¥61.80 Million |
Industry Comparison
This section compares Zhejiang Int'L Group Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - General industry.
Industry Context
- Industry: Drug Manufacturers - General
- Average net assets among peers: $861,031,721
- Average return on equity (ROE) among peers: 7.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Zhejiang Int'L Group Co Ltd (000411) | CN¥5.36 Billion | 19.52% | 2.23x | $199.04 Million |
| Zhejiang Zhenyuan Share Co Ltd (000705) | $485.74 Million | 1.60% | 0.77x | $307.06 Million |
| Hunan Jingfeng Pharmaceutical (000908) | $336.40 Million | 0.81% | 1.44x | $202.85 Million |
| Hubei Guangji Pharmaceutical Co Ltd (000952) | $1.49 Billion | 3.37% | 0.66x | $229.65 Million |
| Zhejiang Haisen Pharmaceutical Co. Ltd. A (001367) | $1.25 Billion | 8.38% | 0.07x | $144.69 Million |
| Yifan Xinfu Pharmaceutical Co Ltd (002019) | $507.64 Million | 23.17% | 1.09x | $1.01 Billion |
| Guangdong Jiaying Pharmaceutical Co Ltd (002198) | $226.35 Million | 6.06% | 0.04x | $447.60 Million |
| Chongqing Lummy Pharmaceutical (300006) | $1.88 Billion | -4.66% | 0.52x | $475.43 Million |
| Zhejiang Jolly Pharmaceutical Co Ltd (300181) | $1.39 Billion | 1.50% | 0.52x | $1.19 Billion |
| Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) | $181.38 Million | 29.65% | 0.05x | $893.83 Million |